Jun Ling
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Jun Ling has a total of 3 co-authors. Here are the top co-authors by number of shared publications:
- A Holly Eckelhoefer
Division of Biomedical Sciences, University of California, Riverside CA 92521, USA
1 shared publication - David D. Lo
Division of Biomedical Sciences, University of California Riverside School of Medicine
1 shared publication Raj Kumar
1 shared publication
Latest Publications
- 1 September 2012
- Published by Elsevier in Cancer Letters
- Vol. 322 (2) , 119-126
Crosstalk between NFkB and glucocorticoid signaling: A potential target of breast cancer therapy
- 1 September 2012
- Published by Elsevier in Cancer Letters
- Vol. 322 (2) , 119-126
Crosstalk between NFkB and glucocorticoid signaling: A potential target of breast cancer therapy
- Open Access
- 13 March 2012
- Published by Springer Nature in BMC Biotechnology
- Vol. 12 (1) , 7
M cell targeting by a Claudin 4 targeting peptide can enhance mucosal IgA responses
Mucosal immune surveillance is thought to be largely achieved through uptake by specialized epithelial M cells. We recently identified Claudin 4 as an M cell target receptor and developed a Claudin 4 targeting peptide (CPE) that can mediate uptake of nanoparticles through Nasal Associated Lymphoid Tissue (NALT) M cells.
- 13 March 2012
- Published by Springer Nature in BMC Biotechnology
- Vol. 12 (1) , 7
Open AccessM cell targeting by a Claudin 4 targeting peptide can enhance mucosal IgA responses
Mucosal immune surveillance is thought to be largely achieved through uptake by specialized epithelial M cells. We recently identified Claudin 4 as an M cell target receptor and developed a Claudin 4 targeting peptide (CPE) that can mediate uptake of nanoparticles through Nasal Associated Lymphoid Tissue (NALT) M cells.